Remicade's approval for ulcerative colitis raises questions about new high-tech versus older approaches
November 2005
Remicade's approval for ulcerative colitis raises questions about new high-tech versus older approaches.
Over 500,000 Americans try various drugs for ulcerative colitis. About 85% of patients with severe disease end up with a colectomy when the drugs don't work.
But this is changing.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote